Primmune Therapeutics Presents Data from Phase 1 Study Evaluating PRTX007 in Healthy ...

Retrieved on: 2022-04-10 02:22:50

Tags for this article:

Branches of biology

Clinical medicine

Plasmacytoid dendritic cell

TLR7

Immune checkpoint

Inflammatory cytokine

Papillomaviridae

Immunotherapy

Click the tags to see associated articles and topics

Primmune Therapeutics Presents Data from Phase 1 Study Evaluating PRTX007 in Healthy .... View article details on HISWAI: https://pipelinereview.com/index.php/2022040980647/Small-Molecules/Primmune-Therapeutics-Presents-Data-from-Phase-1-Study-Evaluating-PRTX007-in-Healthy-Volunteers-at-the-2022-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

Excerpt

... PRTX007 to be used in combination with immune checkpoint inhibitors— ... a biotech company harnessing the power of the innate immune system to ...

Article found on: pipelinereview.com

View Original Article